Clinical Trials Logo

Clinical Trial Summary

Traditionally, strength training and power is the main objective of providing only muscle conditioning, without possible gains on the VO2Max, however, not for aerobic performance.


Clinical Trial Description

A total of 10 visits will be performed. The subjects will be divided into two exercise groups: 1) control group (CG) who performed only aerobic activity of running or walking at moderate intensity (65% VO2max); and 2) strength and power exercise group (GFP), which held the protocol circuit. On the first visit the subjects answer an initial questionnaire of risk stratification for coronary artery disease, and performed a maximal aerobic exercise test.

The subjects performed the interval protocol with strength and power exercises at high intensity in circuit. 20 seconds stimuli will be provided with 10 seconds passive recovery, totaling 4 minutes. In the last session the subjects will be performed the same initial procedures adopted in the first visit to determine the values of VO2max after training. The control group will be performed just one training session total run time conducted in eight sessions by GFP group (approx. 30 min). ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT02642328
Study type Interventional
Source Universidade Federal do Rio de Janeiro
Contact Alberto S. Sá Filho, Dr.
Phone 55 21 998294879
Email albsouzar9@yahoo.com.br
Status Not yet recruiting
Phase N/A
Start date January 2016
Completion date March 2016

See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1